SCHEMBL4331152

SCHEMBL4331152

O=C(NCc1ccccc1)c1nc(-c2cccc(Cl)c2)n2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 3/20 0.50
CNR2 P34972 2/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TP53 P04637 3/20 0.46
THRB P10828 1/20 0.46
MEN1 O00255 1/20 0.46
HCRTR1 O43613 1/20 0.46
KMT2A Q03164 1/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
MAPK1 P28482 1/20 0.44
MAPK10 P53779 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4320324 0.96 CNR2 (0.51) PTGER4CNR2CASP3SENP8SENP7
SCHEMBL4326415 0.95 KDM4E (0.49) PTGER4CNR2CASP3SENP8SENP7
SCHEMBL4334935 0.92 PTGER4 (0.47) PTGER4CNR2CASP3SENP8SENP7
SCHEMBL4326084 0.89 CNR2 (0.48) PTGER4CNR2CASP3SENP8SENP7
SCHEMBL4329324 0.88 MAPT (0.46) CNR2TP53THRBKMT2ASMN1; SMN2
SCHEMBL13578099 0.87 CCR1 (0.52) PTGER4CNR2TP53THRBMEN1
SCHEMBL4332820 0.86 CNR2 (0.45) CNR2TP53MEN1KMT2A
SCHEMBL4320342 0.85 ADORA2A (0.46) PTGER4CNR2CASP3SENP8SENP7
Trifluoroacetic Acid SCHEMBL4320038 0.85 CASP3 (0.49) PTGER4CNR2CASP3SENP8SENP7
SCHEMBL4330448 0.85 ADORA2A (0.46) PTGER4CNR2CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. 2009-12-31 US disclosed
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES MERCK & CO., INC. 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325936-A1 IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES CNR2, CNR1, TRPV1 PTGER4 62/4885CNR2 1/4885CASP3 3788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.